CervoMed Inc. (CRVO)

CervoMed Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	-2.17	-5.8	-24.1	-16.14	-11.8
Depreciation & Amortization	0	0	0.09	0.1	0.1
Share-Based Compensation	0.41	0.46	0.9	0.74	0.52
Other Operating Activities	-5.69	2.77	8.6	-0.21	1.33
Operating Cash Flow	-7.45	-2.57	-14.5	-13.55	-9.86
Capital Expenditures	0	0	0	0	0
Investing Cash Flow	0	0	0	0	0
Share Issuance / Repurchase	12.7	0	33.3	18.87	16.21
Other Financing Activities	-1.55	-	-	-0.98	-0.16
Financing Cash Flow	11.15	0	33.3	17.89	16.04
Net Cash Flow	3.7	-2.57	18.8	4.34	6.19
Free Cash Flow	-7.45	-2.57	-14.5	-13.55	-9.86
Free Cash Flow Margin	-104.27%	-	-	-	-
Free Cash Flow Per Share	-2.80	-4.96	-11.17	-18.88	-110.25

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).